20th Annual Report And Survey Of Biopharmaceutical Manufacturing

Annual Report And Survey Of Biopharmaceutical Manufacturing

473+ pages of data-rich analysis to help improve your decision making in biomanufacturing. In-depth analysis of capacity, production trends, benchmarks, and more.

The 2023 20th Annual Report and Survey of Biopharmaceutical Manufacturing Capacity and Production is a comprehensive analysis of trends and opportunities, biotherapeutic developers and contract manufacturing organizations’ current and projected future capacity and production. We also provide case study summaries highlighting a specific issue affecting the industry, an overview of the situation, and a discussion summary.

207 Biopharma companies
138 industry vendors and direct suppliers
25 Countries represented
473 Pages
12 Chapters
200+ Graphs and 20+ Tables
Subject Matter Expert analysis
Independent Sponsoring Organizations

COVERAGE

In-depth analysis of key data, capacity, production trends, and benchmarks
Budget trends and impact of the current economic environment
Downstream purification problems and issues
Current and projected industry bottlenecks
Capacity utilization and current production levels
Capacity bottlenecks – what’s being done to resolve
Production trends and Outsourcing trends
International offshoring through 2028
Range of titers, growth
Disposables: Spending growth; downstream uses; L&E’s; reasons for increasing/ restricting; budget increases; vendor satisfaction
Batch failure rates & trends
Selecting a CMO — Problems & solutions
Quality management & PAT implementation
Hiring and employment growth
Supplier growth rates, and much more